Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesDividends payablesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Payables (2016 - 2025)

cbdMD's Payables history spans 9 years, with the latest figure at $880978.0 for Q4 2025.

  • For Q4 2025, Payables fell 87.11% year-over-year to $880978.0; the TTM value through Dec 2025 reached $880978.0, down 87.11%, while the annual FY2025 figure was $1.2 million, 81.11% down from the prior year.
  • Payables for Q4 2025 was $880978.0 at cbdMD, down from $1.2 million in the prior quarter.
  • Across five years, Payables topped out at $8.0 million in Q1 2025 and bottomed at $880978.0 in Q4 2025.
  • The 5-year median for Payables is $2.7 million (2022), against an average of $3.1 million.
  • The largest annual shift saw Payables skyrocketed 336.13% in 2024 before it crashed 87.11% in 2025.
  • A 5-year view of Payables shows it stood at $3.7 million in 2021, then tumbled by 54.5% to $1.7 million in 2022, then dropped by 7.81% to $1.6 million in 2023, then soared by 336.13% to $6.8 million in 2024, then tumbled by 87.11% to $880978.0 in 2025.
  • Per Business Quant, the three most recent readings for YCBD's Payables are $880978.0 (Q4 2025), $1.2 million (Q3 2025), and $1.2 million (Q2 2025).